"Iguratimod, a Disease-Modifying Anti-Rheumatic Drug, Inhibits Osteoclastogenesis and Bone Resorption through Suppression of the Nuclear Factor of Activated T Cells Signaling Pathway"
written by Jun Shiota, Hidetoshi Murao, Akihiko Miura, Masaaki Mikami, Keiichi Tanaka,
published by Open Journal of Rheumatology and Autoimmune Diseases, Vol.6 No.4, 2016
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
No relevant information.